Descrição

The health and wellness market in China in terms of revenue is set to grow by US$ 1,044 bilhão durante 2021-2027, crescendo a uma taxa composta de crescimento anual (CAGR) de 9.4% durante o período de previsão, de acordo com a empresa de dados e análise StrategyHelix.

O relatório fornece dados atualizados sobre o tamanho do mercado para o período 2017-2020 e previsão para 2027 covering key market aspects like sales value for health and wellness. The China health and wellness market is segmented on the basis of type. Por tipo, it is categorized into consumer healthcare, healthcare infrastructure, healthcare services, non-pharmaceutical product, and pharmaceutical.

The report has profiled some of the key players of the market such as Ikang Healthcare Group Inc., Jiangsu Hengrui Medicine Co. Ltda., Meinian Onehealth Healthcare Holdings Co. Ltda., Ping An Health Insurance Company of China Ltd., Shanghai Pharmaceuticals Holding Co. Ltda., Sino Biopharmaceutical Limited, Yunnan Baiyao Group Co. Ltda..

O relatório é um recurso inestimável para empresas e organizações ativas neste setor. It provides a cohesive picture of the health and wellness market to help drive informed decision making for industry executives, decisores políticos, acadêmico, e analistas.

Escopo do relatório

Tipo: consumer healthcare, healthcare infrastructure, healthcare services, non-pharmaceutical product, and pharmaceutical
Anos considerados: este relatório cobre o período 2017 para 2027

Principais benefícios para as partes interessadas

Get a comprehensive picture of the China health and wellness market
Identifique setores de crescimento e tendências para investimento
Understand what the future of the health and wellness market in China looks like
Identifique o cenário competitivo e a janela de oportunidade

Índice

1. Definição de mercado
2. Metodologia de Pesquisa
3. Dados de mercado & Panorama
3.1 Valor de mercado
3.2 Previsão de valor de mercado
4. Health and Wellness Market by Type
4.1 Consumer Healthcare
4.2 Healthcare Infrastructure
4.3 Healthcare Services
4.4 Non-Pharmaceutical Product
4.5 Pharmaceutical
5. Perfis de empresa
5.1 Ikang Healthcare Group, Inc..
5.2 Jiangsu Hengrui Medicine Co., Ltda.
5.3 Meinian Onehealth Healthcare Holdings Co., Ltda.
5.4 Ping An Health Insurance Company of China, Ltda.
5.5 Shanghai Pharmaceuticals Holding Co., Ltda.
5.6 Sino Biopharmaceutical Limited
5.7 Yunnan Baiyao Group Co., Ltda.
6. Apêndice
6.1 Sobre StrategyHelix
6.2 Isenção de responsabilidade